Cargando…
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
The A/T/N research framework has been proposed for the diagnosis and prognosis of Alzheimer's disease (AD). However, the spatial distribution of ATN biomarkers and their relationship with cognitive impairment and neuropsychiatric symptoms (NPS) need further clarification in patients with AD. We...
Autores principales: | Dang, Mingxi, Chen, Qian, Zhao, Xiaobin, Chen, Kewei, Li, Xin, Zhang, Junying, Lu, Jie, Ai, Lin, Chen, Yaojing, Zhang, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842886/ https://www.ncbi.nlm.nih.gov/pubmed/36647262 http://dx.doi.org/10.1002/hbm.26043 |
Ejemplares similares
-
Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: a systematic review of symptom-general and –specific lesion patterns
por: Chen, Yaojing, et al.
Publicado: (2021) -
Naoxin’an capsules protect brain function and structure in patients with vascular cognitive impairment
por: Lu, Hui, et al.
Publicado: (2023) -
Divergent brain regional atrophy and associated fiber disruption in amnestic and non-amnestic MCI
por: Du, Chao, et al.
Publicado: (2023) -
Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
por: Dang, Mingxi, et al.
Publicado: (2023) -
Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
por: Arenare, Giulia, et al.
Publicado: (2023)